SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-057991
Filing Date
2024-05-07
Accepted
2024-05-07 16:06:12
Documents
5
Effectiveness Date
2024-05-07

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2413675d1_s8.htm S-8 46533
2 EXHIBIT 5.1 tm2413675d1_ex5-1.htm EX-5.1 9086
3 EXHIBIT 23.2 tm2413675d1_ex23-2.htm EX-23.2 2009
4 EX-FILING FEES tm2413675d1_ex-filingfees.htm EX-FILING FEES 12574
5 GRAPHIC tm2413675d1_ex5-1img01.jpg GRAPHIC 10211
  Complete submission text file 0001104659-24-057991.txt   80071
Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-279169 | Film No.: 24921795
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)